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ABSTRACT
Knee Osteoarthritis (OA) is a common musculoskeletal disorder in the United States. When diagnosed at early stages, lifestyle
interventions such as exercise and weight loss can slow OA progression, but at later stages, only an invasive option is available:
total knee replacement (TKR). Though a generally successful procedure, only 2/3 of patients who undergo the procedure report
their knees feeling “normal” post-operation, and complications can arise that require revision. This necessitates a model to
identify a population at higher risk of TKR, particularly at less advanced stages of OA, such that appropriate treatments can be
implemented that slow OA progression and delay TKR. Here, we present a deep learning pipeline that leverages MRI images
and clinical and demographic information to predict TKR with AUC 0.834±0.036 (p < 0.05). Most notably, the pipeline predicts
TKR with AUC 0.943±0.057 (p < 0.05) for patients without OA. Furthermore, we develop occlusion maps for case-control pairs
in test data and compare regions used by the model in both, thereby identifying TKR imaging biomarkers. As such, this work
takes strides towards a pipeline with clinical utility, and the biomarkers identified further our understanding of OA progression
and eventual TKR onset.
Introduction
Knee Osteoarthritis (OA) is one of the most common musculoskeletal disorders in the United States, with estimates of its
incidence rate ranging from 14 to 30 million1, 2. Annual arthritis-related medical expenditures are nearly $140 million, and hip
and knee OA together are the 11th highest contributor to global disability3, 4. The propensity of knee OA to induce eventual
disability can be attributed to structural changes in the joint that characterize the disease, as well as symptoms that can include
inflammation, debilitating pain, and functional limitations5, 6. Progression of the full-joint disease is typically assessed using the
Kellgren-Lawrence (KL) scale, a 0-4 scale in which a higher score is associated with narrowing of the tibiofemoral joint (TFJ)
space and other radiographic changes, and thus, a more advanced stage of knee OA7. When diagnosed at early stages (KL = 0,
1), knee OA can be managed through nonsurgical treatment options, including exercise and/or weight loss, oral medications
such as acetaminophen or NSAIDs, or intra-articular injections such as corticosteroids and hyaluronic acid, all of which have
varying degrees of success in reducing pain8. At late stages (KL = 4), however, no noninvasive option exists9; here, the only
option is total knee replacement (TKR).
TKR is an elective procedure in which the knee joint is resurfaced with a metal or plastic implant intended to restore
function, provide pain relief, and improve quality of life10. In the United States, estimates of TKR incidence lie at 400,000 each
year, a figure expected to grow 143% by 2050 even through conservative projections11. While TKR is considered one of the
most effective procedures in orthopedic surgery, electing for it is far from straightforward: noninvasive alternatives such as
weight loss, physical therapy, and NSAIDs are first exhausted. If unsuccessful, a patient will undergo a thorough examination of
clinical history and comprehensive imaging of the joint to determine if a TKR is feasible, and if so, the desired implant design
and size12, 13. The procedure is also imperfect: only 66% of patients report their knees feeling “normal,” and 33% of patients
report some degree of pain post-implant14. Furthermore, the implant can fail under some circumstances: periprosthetic joint
infection and wound complications can be observed, and implant instability can occur due to aseptic loosening, malpositioning
of the implant, and wear of joint components15, 16. It is thus much preferable to prolong the good health of the knee, particularly
in patients where OA has not advanced to the most severe stages, thereby delaying TKR as long as possible. This necessitates a
model to identify patients at higher risk of TKR such that appropriate treatment options can be pursued.
Given the multitude of factors on which a decision to pursue TKR is made, devising a model to predict if the invasive
intervention will be necessary is a difficult task, but with obvious utility. For a patient in earlier stages of OA, a model predicting
the patient to be at risk of TKR can be the impetus for a more aggressive nonsurgical treatment. Meanwhile, for a late-stage OA
patient, a model predicting them to undergo TKR may facilitate a doctor and patient opting for the treatment earlier than they
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otherwise would, thereby reducing time spent pursuing nonsurgical alternatives with minimal probability of success while
dealing with serious pain. Beyond this, if the model were to draw from medical images of the knee, it could identify anatomic
regions most correlated with a TKR prediction. To this point, few studies have been conducted in this space, and those that
have primarily investigate the importance of cartilage volume loss, subchondral bone defects, and bone marrow lesions17–19.
An identification of more such biomarkers for TKR, however, could greatly improve understanding of both OA and TKR, and
ultimately guide treatment strategies.
Predictive modeling of TKR, however, has a limited history, particularly with models that use medical images. A few
studies have leveraged random forest regression, Cochran-Armitage tests for trend, and t-tests to identify demographic, general
health, and physical examination measurements that most strongly correlate with TKR or total joint arthroplasty (TJA)20, 21.
Others have taken these efforts further, using techniques such as multiple regression and multivariate risk prediction models to
predict TKR outright22, 23. To our knowledge, only one group has developed a predictive model of TKR that accepts image
inputs, attaining performance that surpasses that of models using only clinical and demographic information24. Notably, past
TKR predictive models largely measure performance by evaluating the area under the receiver operating characteristic (ROC)
curve, which plots true positive rate against false positive rate25. However, in most datasets used in this space, the number
of patients who eventually undergo TKR is dramatically higher among those who have advanced OA as opposed to those
with no or moderate OA. Consequently, this performance metric (AUC), while effectively capturing a model’s combination of
sensitivity and specificity, can be inflated for TKR prediction by indiscriminately predicting patients without OA not to undergo
TKR, while more accurately predicting patients with severe OA to undergo TKR, the latter of which is easier. As a result, while
past works have made clear progress in predicting TKR, none have overcome datasets imbalanced with respect to OA severity
to report sensitive and specific prediction at these early stages, where a model would have the most utility.
One technique that has shown promise in delivering such performance is deep learning (DL). DL, especially convolutional
neural networks (CNNs), has made strides in image classification tasks, attaining performances on the popular ImageNet
classification challenge that approach or surpass human performance26–28. DL shines when afforded large datasets, as its
automated feature extraction allows one to solve problems too complex for conventional approaches29. Given the complex
prognostic features in TKR recommendation, CNNs become more promising for TKR prediction. In the past, DL had seen
limited utility in OA and TKR prediction due to the large dataset requirement for efficacy; that limitation has been somewhat
mitigated by the curation of large-sized cohort studies such as the Osteoarthritis Initiative (OAI)30. Consequently, DL has
recently been applied for knee OA classification and progression prediction9, 31, 32. The success of these works further suggests
the feasibility of leveraging DL to predict TKR.
In this study, we formulate a DL-based pipeline that incorporates knee joint images in addition to clinical and demographic
information to predict the onset of TKR (Fig. 1). We demonstrate that the pipeline’s predictions using solely Magnetic
Resonance Imaging (MRI) images matches that of past work, while the integration of MRI image-based predictions with non-
imaging variables facilitates TKR prediction with especially high sensitivity and specificity for patients without radiographic
OA. Furthermore, we show the increase in pipeline performance when using 3D MRI images as opposed to 2D radiographs,
suggesting MRI may have a role in TKR risk screening despite higher costs and more limited availability. And finally, we
leverage occlusion maps to conduct a thorough analysis of tissues that most significantly affect the output model metric
associated with TKR prediction confidence, thereby identifying a set of imaging biomarkers for eventual TKR onset.
Novelty
This work reports a methodology and results that are novel in the following manners:
1. This model is the first to apply a 3-dimensional DenseNet CNN for prediction of TKR from MRI.
2. The TKR prediction model is evaluated for patients stratified by OA severity, which has not been reported in previous
studies.
3. With the aim of improving model interpretability and clinical utility, we report the first comprehensive, case-control
study to identify imaging biomarkers for TKR.
Materials and Methods
Data
Data was acquired from a prospective observational study conducted by OAI. The dataset followed 4,796 patients and acquired
images including 2D posteroanterior radiographs and 3D Sagittal Double Echo Steady-State (DESS) MRI images over the
course of 10 years. Details of data collection and study design have been previously reported30. The OAI study protocol
was approved by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and is registered on
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Figure 1. Pipeline predicting if patient will undergo TKR within 5 years from MRI/X-ray images and non-imaging variables.
MRI and X-ray images are center-cropped and cropped to a region centered around the joint, respectively, and normalized.
DenseNet-121 is pretrained to predict OA and fine-tuned to predict TKR. Image-based predictions and clinical information are
fed to a logistic regression (LR) ensemble based on OA severity. Each ensemble, whose hyperparameters were optimized for
Youden’s index in a hyperparameter search, averages predictions of LR models in its OA severity for final TKR prediction.
Pipeline is subsequently analyzed through occlusion map analysis to identify imaging biomarkers of TKR.
ClinicalTrials.gov as “Osteoarthritis Initiative (OAI): A Knee Health Study”, NCT#00080171. The study was carried out in
accordance with all pertinent guidelines, and written consent was obtained from participants prior to each clinical visit in the
study.
Both posteroanterior radiographs and DESS MRI images were evaluated as data sources for TKR prediction models.
Patients for whom KL grade was not recorded at any point in the longitudinal study were excluded. To homogenize datasets,
radiograph and MRI images were only taken from patients and time points at which both were available (n = 35,482). We
labeled entries as cases if the patient underwent a first TKR within 5 years of the given time point (n = 1,043). We labeled
entries as controls if patients did not undergo a TKR or eventually underwent one but the time to it was longer than 5 years (n =
34,439). Contralateral TKRs were not considered.
The radiographs and MRI images were preprocessed for training and model evaluation. Radiographs were cropped to
a 500× 500 region centered around the knee joint. Briefly, 2D cross-correlation template matching was used to identify a
500×500 bounding box centered around the knee joint in 450 joints, and these cases were used to train a U-Net architecture
that identified this region for all posteroanterior radiographs from the OAI study32. DESS MRIs were center-cropped to a
120×320×320 region, after which both sets of cropped images were normalized. Normalized MRI pixel values were then
rounded to nearest integers, compressing the MRI image to 14 possible pixel values. This rounding approach was initially
tested as a strategy to accelerate training of a 3D CNN, given the large imaging volumes and large dataset on which it was
being trained, believing the approach could suppress information extraneous to eventual TKR. Empirically, this approach
yielded superior validation performance to leaving pixel values unrounded, so it was utilized. Examples of the results of this
compression strategy are in Supplementary Fig. 5.
Non-imaging variables were screened for among studies and reviews detailing risk factors for knee OA progression and
TKR onset21–23, 33–36. Variables such as KL grade known to be deducible directly from MRI images and radiographs were not
considered. From these studies, 40 non-imaging variables of interest were identified (see Supplementary Table 6). The OAI
database was then parsed for corresponding variables, and these corresponding variables were added as potential non-imaging
variables for our study, yielding 44 potential non-imaging variables. In some cases, multiple OAI metrics corresponded to
non-imaging variables of interest, causing the number of OAI non-imaging variables to exceed what was identified from
literature. Missing data points were imputed with k-nearest neighbors. These potential variables were used to train a random
forest with 100 trees to predict onset of TKR within 5 years, and the minimum depth at which each feature was used across all
trees in the forest was identified. Features whose minimum depth was below the average minimum depth of all features were
preserved as non-imaging variables37. This yielded 27 non-imaging variables that are displayed in Table 1.
The data were then split into training, validation, and test with a 65%/20%/15% split, ensuring entries of any patient were
only in one of the three datasets to prevent data leakage. Within the training set, imbalance between TKR and non-TKR cases
was addressed with data augmentation, drawing bootstrap samples from the rare class with replacement38. A summary of
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Non-imaging variables used to augment image-based predictions
Age Comorbidity score
BMI Injections to treat arthritis in previous 6 months
Education Seen physician for arthritis in previous year
Ethnicity Knee valgus negative alignment (degrees)
Income Isometric leg strength
NSAID usage Back pain in previous 30 days
Analgesics usage Difficulty squatting in previous 7 days
Systolic BP Difficulty kneeling in previous 7 days
Considering TKR Baseline frequency knee pain status
PASE Previous knee injury that limited walking
KOOS QOL 0-10 global rating assessing effect of knee pain
KOOS pain SF-12 physical component score
WOMAC pain SF-12 mental component score
WOMAC disability
Table 1. List of non-imaging variables fed into logistic regression models to make TKR onset predictions. Abbreviations used:
Body Mass Index (BMI), Nonsteroidal Anti-inflammatory drugs (NSAIDS), Blood Pressure (BP), Physical Activity Scale for
the Elderly (PASE), Knee Injury and Osteoarthritis Outcome Score (KOOS), Quality of Life (QOL), Western Ontario and
McMaster Universities Arthritis Index (WOMAC), Short Form 12 (SF-12).
the data prior to augmentation is provided in Table 2, detailing the number of cases and controls while showing descriptive
statistics regarding demographics in each of the three datasets.
Pipeline architecture
The DL-based pipeline is based on a DenseNet-121 with the following parameters: 16 filters in initial layer, growth rate of 32,
pooling block configuration of [6, 12, 24, 16], 4 bottleneck layers, 2 classes. The same architecture was used for the radiograph
and MRI pipelines, but for the MRI pipeline, we modified the convolutional layers, batch normalization layers, pooling layers,
and leaky rectified linear unit (ReLU) layers to allow for 3D image input39. The network yielded a scalar reflecting certainty
of TKR within 5 years, which was added to the non-imaging variables. The 28 resulting variables were fed into one of three
sets of Logistic Regression (LR) ensembles, with each ensemble optimized to maximize sensitivity and specificity in cases of
no (KL = 0, 1), moderate (KL = 2, 3), and severe OA (KL = 4). Based on the KL grade of a sample, it was fed into an LR
ensemble, yielding a prediction as to whether the patient will undergo a TKR within 5 years.
Dataset Datatype Age BMI
KOOS
pain Male Female
OA status Total
entries
Unique
patientsNone Moderate Severe
Training
Control 62.5±9.15
28.3±
4.75
87.2±
16.2 9,708 12,731 12,721 8,950 768 23,126 3,114
Case 66.3±8.38
29.6±
4.79
67.2±
19.6 291 396 41 357 289
Valid.
Control 62.4±9.21
28.4±
4.64
87.6±
15.9 2,876 4,035 4,118 2,611 182 7,115 957
Case 66.1±8.76
29.8±
4.61
66.2±
19.1 70 134 13 93 98
Test
Control 62.8±9.55
28.4±
4.81
87.4±
16.5 2,126 2,963 2,892 2,056 141 5,241 719
Case 66.4±7.78
29.9±
3.96
68.7±
20.6 59 93 12 83 57
Table 2. Data used to train 3D DESS MRI and 2D radiograph architectures. After exclusion criteria were applied, 35,482
qualifying entries were found in the OAI dataset across 4,790 unique patients, all of which were split into training, validation,
and test sets as displayed in table. To prevent data leakage, all entries from any given patient were only allowed to be in one of
the three sets. S.d. is reported for age, BMI, and KOOS pain score within the table.
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Training
A DenseNet-121 was initially pretrained to predict knee OA using the entire training set, assessing cross-entropy loss and
accuracy on the validation set after completion of each epoch. The pre-train was stopped when validation loss began to increase.
The pretrained model was subsequently fine-tuned to predict TKR. We utilized a random search to determine optimal learning
rate, dropout rate, weights of the cross-entropy loss function, and number of layers to freeze during fine-tuning. The search
was carried out for 25 iterations, after which a set of parameters were selected that yielded the best combination of accuracy,
sensitivity, and specificity on the validation set. Due to computational intensity, the hyperparameter search was not conducted on
the entire dataset: for the 2D DenseNet-121, 10% of training and validation sets were used, whereas for the 3D DenseNet-121,
2.5% of both were used. After the search, the model fine-tuned using the subset of the training set was further fine-tuned on the
entire training set using optimal parameters until validation loss began to increase. The test set was held out during training and
predictions for it evaluated just once after fine-tuning, which marked the end of model optimization.
Integration of Imaging and Non-Imaging Data
Random forest regression, support vector machine, neural network, and LR architectures were assessed for efficacy of integrating
imaging and non-imaging predictions, with LR providing best results on validation data. The LR architecture was thus used:
all 28 imaging and non-imaging models were fed into an LR model, the optimal parameters of which were also identified
through a random search. The search was conducted for 100 iterations, seeking to optimize the cross-entropy loss function
weights afforded to both classes. For the cases of no, moderate, and severe OA, ideal parameters were identified by selecting
those that maximized Youden’s index within each OA classification in the search40. Predictions of the best few models in
each classification were averaged to yield final TKR predictions. The number of predictions averaged in each classification
was selected by finding a value that optimized validation accuracy, AUC, and Youden’s index. The resulting LR models were
ensembled and run on test data just once. Confidence intervals of accuracy, sensitivity, and specificity for each OA severity
were obtained by bootstrapping, sampling 100% of test data with replacement (B = 100). Confidence intervals for AUC were
calculated in the same manner. Results are reported on 3 versions of each model: the sole DenseNet-121 output (image only),
output of a single LR model trained to predict TKR using solely the 27 non-imaging variables while not weighting the loss
function class weights (non-imaging info. only), and output of the LR ensemble with image predictions (integrated model).
Statistical Analysis
The accuracies of X-ray and MRI pipeline performances within each OA classification and overall were compared using
McNemar’s test41, 42. This test was appropriate because it specifically tests for differences in a dichotomous variable in matched
groups. In our case, the variable was correct TKR prediction and the groups were the X-ray and MRI pipelines. Initially, the
McNemar test statistic was modeled with a chi-squared distribution to test for significant differences between the pipelines, and
if one existed, a binomial distribution was used to interrogate which pipeline yielded the significantly higher performance. All
tests were carried out at α = 0.05.
Relative sensitivity and specificity of the X-ray and MRI pipelines were assessed by comparing their AUCs within each
OA classification and overall. This test is appropriate because the ROC curve plots true positive rate (sensitivity) against false
positive rate (1 – specificity); consequently, the closer the AUC is to 1, the better the combination of sensitivity and specificity.
100% of test data was sampled with replacement (B = 100), and for each corresponding pair of X-ray and MRI pipelines
(matched by OA classification and use of images only or both image and non-image information), AUCs were calculated. To
test if one outperformed the other, differences in AUCs were calculated at each iteration, and the mean and standard deviation
of the differences used to conduct a student’s t-test with 99 degrees of freedom. This test is applicable on each matched pair of
X-ray and MRI pipelines due to the number of iterations for which test data was sampled, allowing the central limit theorem to
apply. For confidence intervals, mean and standard deviation of AUCs of individual models were calculated and used to report
95% intervals.
Imaging biomarker identification
For all 124 true positives in the test data for the integrated MRI pipeline, corresponding controls were identified by randomly
sampling from test data true negatives, keeping OA status distributions identical and using a student’s t-test with 123 degrees
of freedom to ensure no significant difference in KOOS pain scores across cases and corresponding controls at α = 0.05.
Occlusion maps were generated for all cases and controls using voxel size of 12×32×32 and stride of 12. For each pixel,
the value displayed represented the magnitude of change in the scalar pipeline output resulting when that pixel was occluded,
averaged across all occlusions in which that pixel existed. Pixels for which scalar pipeline output change lied in the top 5%
were designated as “hotspots.” Anatomic regions of these hotspots were identified and odds ratios (OR) calculated to interrogate
possible imaging biomarkers of TKR. 95% OR confidence intervals were calculated for each anatomic region investigated in
this analysis using Cornfield’s method, as this method performs well with relatively small sample sizes43. P values of ORs were
calculated using a two-tailed Fisher’s exact test44. Tissues where p values fell below the significance level of α = 0.05 and in
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OA
status
Model
type
Accuracy
(95% CI)
Sensitivity
(95% CI)
Specificity
(95% CI)
Non-TKR
cases
TKR
cases
None Radiograph 92.1±0.083 25.2±2.16 92.4±0.081 2,892 12
MRI 94.3±0.070 48.7±2.48 94.4±0.070
Moderate Radiograph 29.3±0.151 93.8±0.439 26.7±0.156 2,056 83
MRI 65.4±0.154 65.5±0.848 65.4±0.158
Severe Radiograph 29.7±0.488 100.0±0.000 1.4±0.180 141 57
MRI 33.4±0.523 82.2±0.824 14.0±0.441
All Radiograph 64.2±0.124 90.7±0.378 63.4±0.126 5,089 152
MRI 80.2±0.079 70.4±0.595 80.5±0.082
Table 3. Performance in TKR prediction of OA pretrained models for radiographs and MRI, stratified by severity of OA.
Pretraining strategy yields useful information to both models, but performance at no OA in particular leaves room for
improvement, justifying subsequent model fine-tuning. Standard errors used to calculate confidence intervals.
which 95% OR confidence intervals did not include 1 were deemed significant. These test selections were appropriate, as they
allowed for direct comparison of the frequencies at which several tissues were hotspots across cases and controls, and as such,
identified significant tissues with regards to TKR onset.
Results
OA pretrain utility in TKR prediction
To test information learned from the OA pretrain, pretrained models themselves were used to predict TKR, with results depicted
in Table 3. Predictably, the radiograph OA pretrain model had poor sensitivity for patients without OA, and poor specificity
in moderate and severe cases of OA. While the MRI OA pretrain model expectedly yielded more balanced sensitivity and
specificity across all OA stages, it too left room for improvement, particularly in sensitivity at no OA and specificity at severe
OA. This confirmed the pretrain provided useful information to both architectures but fine-tuning and integration of non-imaging
variables were necessary to attain desired TKR prediction performance.
X-ray pipeline optimization and performance
For the X-Ray model, hyperparameter tuning steps found the following to yield the best combination of validation accuracy,
sensitivity, and specificity: learning rate of 3.981×10−6, TKR class weight in cross-entropy loss function of 0.927 and
non-TKR class weight of 0.073, dropout rate of 0.375, and only the last 2 layers fine-tuned after OA pretrain.
A radiograph model was fine-tuned to predict TKR with these parameters, and its predictions fed into an LR ensemble.
Averaging predictions of the best 5 LR models found through random search in the 3 OA categories yielded best validation
performance, so this ensemble was used on the test set. Test accuracy, sensitivity, and specificity are provided in Table 4,
and ROC curves of all three versions of this pipeline are found in Fig. 2a. AUCs are as follows: 0.848± 0.039 (image
only), 0.868±0.028 (non-imaging info. only), 0.890±0.021 (integrated model). Furthermore, AUCs for the image-only and
combined versions of the pipeline at no OA are as follows: 0.514± 0.087 (image only); 0.799± 0.055 (integrated model).
At moderate OA: 0.788±0.025 (image only); 0.865±0.016 (integrated model). At severe OA: 0.552±0.040 (image only);
0.641±0.044 (integrated model). All AUC intervals are calculated using standard deviation (s.d.), p < 0.05.
MRI pipeline optimization and performance
Similarly, a hyperparameter search was carried out for the MRI pipeline to optimize parameters for eventual fine-tuning. The
following hyperparameters were found optimal: learning rate of 1.906×10−2, TKR class cross-entropy weight of 0.902 and
non-TKR class weight of 0.098, dropout rate of 0.329, only last layer of model fine-tuned after OA pretrain.
An MRI-based model was fine-tuned from these parameters. The resulting predictions were fed into an LR ensemble,
where averaging predictions of the best 4 models in each OA category optimized validation performance. Performance of the
resulting architecture on test data is reported in the same manner as the radiograph pipeline, in Table 4 and Fig. 2b. AUCs are
as follows: 0.886±0.020 (image only), 0.868±0.028 (non-imaging info. only), 0.834±0.036 (integrated model). AUCs for
the image-only and combined pipeline versions at no OA are as follows: 0.897±0.039 (image only); 0.943±0.029 (integrated
model). At moderate OA: 0.764±0.020 (image only); 0.830±0.024 (integrated model). At severe OA: 0.560±0.042 (image
only); 0.726±0.038 (integrated model). Again, all AUC intervals are calculated using s.d., p < 0.05.
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OA
status
Image
source Model type
Accuracy
(95% CI)
Sensitivity
(95% CI)
Specificity
(95% CI)
Non-TKR
cases
TKR
cases
None
X-ray
Non-imaging info. only 89.1±0.139 49.7±2.80 89.3±0.140
2,892 12
Image only 95.0±0.089 7.8±1.64 95.4±0.089
Integrated Model 95.4±0.081 8.6±1.95 95.8±0.077
MRI
Non-imaging info. only 89.1±0.139 49.7±2.80 89.3±0.140
Image only 95.2±0.088 66.9±3.23 95.3±0.089
Integrated Model 82.4±0.171 92.2±1.68 82.4±0.173
Moderate
X-ray
Non-imaging info. only 72.9±0.208 70.0±1.16 73.0±0.212
2,056 83
Image only 79.9±0.196 66.7±1.23 80.4±0.195
Integrated Model 81.4±0.178 76.0±1.12 81.6±0.179
MRI
Non-imaging info. only 72.9±0.208 70.0±1.16 73.0±0.212
Image only 68.8±0.225 78.3±0.952 68.4±0.227
Integrated Model 74.9±0.216 78.9±0.974 74.7±0.228
Severe
X-ray
Non-imaging info. only 51.3±0.744 89.4±0.864 35.8±0.925
141 57
Image only 32.1±0.714 94.5±0.735 7.2±0.467
Integrated Model 60.5±0.775 64.0±1.57 59.0±0.959
MRI
Non-imaging info. only 51.3±0.744 89.4±0.864 35.8±0.925
Image only 34.6±0.775 98.3±0.390 9.2±0.632
Integrated Model 59.6±0.770 84.0±1.03 49.6±1.04
All
X-ray
Non-imaging info. only 81.1±0.118 75.6±0.776 81.2±0.122
5,089 152
Image only 86.4±0.095 72.5±0.864 86.9±0.095
Integrated Model 88.4±0.094 66.3±0.924 89.1±0.090
MRI
Non-imaging info. only 81.1±0.118 75.6±0.776 81.2±0.122
Image only 82.1±0.118 84.9±0.636 82.1±0.119
Integrated Model 78.5±0.134 81.8±0.643 78.4±0.138
Table 4. Performance of X-ray and MRI architectures on test data. While integrated X-ray pipeline delivers higher accuracy
than integrated MRI pipeline, integrated MRI pipeline yields improved sensitivity over integrated X-ray pipeline across all
stages of OA, markedly so at no OA. Standard errors used to calculate confidence intervals.
Comparison of MRI and radiograph pipeline performances
A comparison of overall AUCs attained by the integrated MRI and X-ray pipelines across OA grades and overall shows that at
no OA and severe OA, the MRI pipeline outperformed the X-ray pipeline (No OA, B = 100: p = 3.04×10−2; Moderate OA, B
= 100: p = 9.55×10−1; Severe OA, B = 100: p = 4.57×10−2; Overall, B = 100: p = 9.94×10−1). The MRI pipeline thus has
a superior combination of sensitivity and specificity than does the X-ray pipeline for patients without OA and those with severe
OA. The AUCs obtained by the image-only pipelines also were compared, and showed the MRI pipeline to outperform the
X-ray pipeline for patients without OA and overall (No OA, B = 100: p = 6.10×10−5; Moderate OA, B = 100: p = 7.58×10−1;
Severe OA, B = 100: p = 4.37×10−1; Overall, B = 100: p = 1.16×10−2). These results follow intuition: while radiographic
imaging is primarily capable of illuminating bones in the joint, MRI can visualize soft tissues such as cartilage, muscle, and
meniscus45, 46. It follows that an MRI model will exhibit a better combination of sensitivity and specificity, especially in
early OA stages at which few radiographic changes in the knee have occurred. ROC curves for pipeline versions and OA
classifications in which the MRI architecture yielded a significantly better AUC than its X-ray counterpart are shown in Fig. 3.
McNemar’s test assessed relative accuracies of these pipelines. There was a statistically significant difference between
the accuracies of the integrated X-ray and MRI pipelines for patients at no OA, moderate OA, and overall (No OA, n = 537:
p = 1.65×10−59; Moderate OA, n = 521: p = 1.13×10−9; Severe OA, n = 47: p = 8.84×10−1; Overall, n = 1,105: p =
1.52×10−54), and in each of those 3 statistically significant cases, the X-ray pipeline outperformed the MRI pipeline (No OA,
n= 537: p = 1.11×10−16; Moderate OA, n = 521: p = 5.97×10−10; Overall, n = 1,105: p = 1.11×10−16). In interpreting
these tests and the AUC tests holistically, it is evident that the X-ray pipeline is able to attain superior accuracy in several OA
classifications by compromising on its combination of sensitivity and specificity. This is further supported by the accuracies
and sensitivities reported for the respective pipelines in Table 4, which show that while the X-ray pipeline is more accurate than
its MRI counterpart at every OA classification, the opposite is true for sensitivity—drastically so for patients without OA. In the
clinic, where sensitivity as to whether a patient is at risk of eventual TKR is paramount, these results would show the MRI
pipeline to be the more useful model.
It is also worthy to note the improvement in performance that occurs for patients without OA when imaging predictions
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Figure 2. ROC curves for X-ray and MRI architectures on test data. X-ray pipeline ROC curves are shown in (a), with AUCs
as follows, p < 0.05: 0.848±0.039 (image only), 0.868±0.028 (non-imaging info. only), 0.890±0.021 (integrated model).
MRI pipeline ROC curves are shown in (b), with AUCs as follows, p < 0.05: 0.886±0.020 (image only), 0.868±0.028
(non-imaging info. only), 0.834±0.036 (integrated model). Standard deviations used to calculate confidence intervals. ROC
curves with AUCs within 1 standard deviation of the mean for each model type during bootstrapping are also shown on plots.
are added to non-imaging variables in both pipelines. In the X-ray pipeline, the model’s AUC increased from 0.514±0.087
to 0.799±0.055 when non-imaging variables were added to the radiographs, a sizeable increase when compared to the MRI
pipeline performance, which saw AUC increase from 0.897±0.039 to 0.943±0.029 (p < 0.05 for all). This demonstrates
that non-imaging variables such as various pain scales seem to add critical information to the X-ray pipeline, while the same
information is less important in the MRI pipeline.
Biomarker identification and analysis
Of the 152 patients in test data who underwent a TKR, 124 were detected by the MRI pipeline. Occlusion maps were generated
for these cases and their corresponding true negative controls, an example of which is shown in Fig. 4. Tissues and their hotspot
percentages across these true positives and corresponding true negative controls can be found in Supplementary Table 7 and
Supplementary Table 8, respectively. ORs, 95% confidence intervals, and associated p values for each tissue can be found in
Table 5.
Three tissues saw ORs and 95% confidence intervals that lied above 1 and p values below α = 0.05: the medial patellar
retinaculum, gastrocnemius tendon, and plantaris muscle. Thus, we conclude there is a substantial and statistically significant
difference in the risk of TKR within 5 years when these tissues are identified as hotspots by the pipeline. From the ORs, we see
that the risk of TKR increases when any of the three are identified as hotspots: for the medial patellar retinaculum, the risk is
1.98 times higher with a 95% confidence interval from 1.02 to 3.99; for the gastrocnemius tendon, it is 2.97 times higher with a
95% confidence interval from 1.12 to 10.0; and for the plantaris muscle, it is 2.84 times higher with a 95% confidence interval
from 1.47 to 5.82. As such, these results provide evidence that all are imaging biomarkers of TKR.
On the other hand, several tissues located within or near the tibiofemoral joint—namely, cartilage and bone in both medial
and lateral locations of the joint, menisci in all tested regions, and the ACL—saw ORs and 95% confidence intervals entirely
below 1 and p values below α = 0.05. Consequently, for all of these tissues, we find a statistically significant difference in
the risk of TKR within 5 years when these tissues are identified as hotspots. In the case of each, the risk of TKR appears
to decrease when these tissues are identified as hotspots. Interestingly, each of these tissues have either been implicated as
imaging biomarkers of OA progression, or damage within them is associated with OA onset47–49. These results, in conjunction
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Figure 3. ROC curves for MRI and X-ray pipelines at selected OA classifications and pipeline versions in which MRI
performance was significantly better than that of X-ray. MRI pipeline outperforms X-ray pipeline at no OA for both image-only
and integrated models, as seen in (a) and (c). As shown in (b), integrated MRI pipeline also outperformed integrated X-ray
pipeline for severe OA patients, while (d) shows image-only MRI pipeline outperformed image-only X-ray pipeline across all
OA stages. AUCs are displayed in the figure with p < 0.05. Standard deviations used to calculate confidence intervals. ROC
curves with AUCs within 1 standard deviation of the mean for each pipeline version during bootstrapping are shown on plots.
with the three tissues in which risk of TKR increased when identified as hotspots, suggest that compared to OA progression,
TKR onset relies less on tissues in and around the tibiofemoral joint and more on tissues in other locations of the joint to make
predictions. TKR has been considered an outcome of OA progression, but these results demonstrate in part how it is a more
nuanced problem.
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Figure 4. Slices of occlusion map of true positive detected by MRI pipeline, overlaid on corresponding slices of DESS MRI.
Such maps were generated and analyzed for all 124 true positives and corresponding true negative controls of the integrated
MRI pipeline.
Discussion
In this work, we present a pipeline that integrates MR imaging and non-imaging features to attain strong TKR prediction
performance, reporting accuracy of 78.5±0.134%, sensitivity of 81.8±0.643%, and specificity of 78.4±0.138% (intervals
calculated with standard error of measurement (s.e.m.), p < 0.05). Comparisons of AUCs showed the MRI pipeline to outperform
the X-ray pipeline for patients without OA and with severe OA, thereby showing the MRI model to have a better combination
of sensitivity and specificity in these OA classifications. That it did so particularly for patients without OA shows the utility of
the MRI pipeline in screening for patients at risk of TKR despite higher costs. It was also interesting that, particularly among
patients with no OA, the X-ray model improved drastically more than the MRI model when non-imaging information was
added, judging by disparities in AUCs. This suggests the MRI-trained DenseNet-121 may have learned to predict some of the
non-imaging features from the images themselves, indicating that MRI images may intrinsically contain information regarding
pain, quality of life, and physical performance, among other non-imaging variables used in this study. The utility of MRI in
predicting these variables through DL is certainly worth further investigation.
A comparison of the MRI pipeline performance to past work is insightful. The closest analog to our work was conducted by
Wang, T. et al.24, who trained independent residual networks to predict TKR from both DESS and Turbo Spin Echo (TSE) MRI
images, integrating both predictions with non-imaging variables in a LR model to yield a final TKR prediction. This yielded a
model with AUC of 0.86±0.01 (p < 0.01) when solely DESS or TSE images were used, and 0.88±0.02 (p < 0.01) when both
images and non-imaging features were integrated. Our MRI image-only model saw AUC of 0.886±0.020 (image only, p <
0.05) and an integrated AUC of 0.834±0.036 (combined, p < 0.05). Our image-only model thus yields performance superior
to its image-only counterpart, with a 95% confidence interval lying entirely above the mean AUC of the image-only model by
Wang, T. et al.24. Our integrated model, as discussed previously, was optimized to maximize Youden’s index within each OA
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Tissue type Tissue OR (95% CI, n = 124) p value (n = 124)
Cartilage
TFJ medial* 0.05 (0.00 - 0.48) 3.36×10−3
TFJ lateral* 0.03 (0.00 - 0.25) 3.89×10−5
PFJ 1.03 (0.60 - 1.77) 1.00
Meniscus
Medial anterior* 0.33 (0.12 - 0.79) 1.04×10−2
Medial posterior* 0.40 (0.16 - 0.89) 2.37×10−2
Lateral anterior* 0.23 (0.05 - 0.67) 5.05×10−3
Lateral posterior* 0.26 (0.06 - 0.80) 1.49×10−2
Bone
TFJ medial* 0.17 (0.00 - 0.91) 3.57×10−2
TFJ lateral* 0.02 (0.00 - 0.22) 8.48×10−6
PFJ 1.11 (0.64 - 1.92) 7.93×10−1
Ligament
ACL* 0.49 (0.23 - 0.99) 4.72×10−2
PCL 1.58 (0.89 - 2.87) 1.27×10−1
Popliteal 1.62 (0.96 - 2.77) 7.51×10−2
Tendon
Medial patellar retinaculum* 1.98 (1.02 - 3.99) 4.19×10−2
Lateral patellar retinaculum 1.08 (0.60 - 1.96) 8.88×10−1
Popliteal 1.49 (0.87 - 2.57) 1.56×10−1
Patellar 1.76 (0.92 - 3.48) 9.00×10−2
Gastrocnemius* 2.97 (1.12 - 10.0) 2.67×10−2
Semimembranosus 0.50 (0.23 - 1.03) 6.17×10−2
Quadriceps 3.18 (0.88 - 20.4) 8.38×10−2
Gracilis 4.52 (0.74 - 290) 1.20×10−1
Fat Pad Hoffa 2.38 (0.92 - 7.38) 7.80×10−2
Muscle
Popliteus 1.98 (1.00 - 4.14) 5.11×10−2
Vastus medialis 1.26 (0.54 - 3.00) 6.93×10−1
Gastrocnemius 1.35 (0.73 - 2.54) 3.76×10−1
Plantaris* 2.84 (1.47 - 5.82) 1.29×10−3
Biceps femoris 4.52 (0.74 - 290) 1.20×10−1
Tibilais anterior 2.37 (0.24 - 161) 6.22×10−1
Semimembranosus 0.35 (0.05 - 1.32) 1.36×10−1
Synovium General 1.17 (0.50 - 2.82) 8.41×10−1
Table 5. Summary of occlusion map analysis comparing hotspot frequencies in selected knee joint tissues. Hotspots were
defined as pixels that, when occluded, were in the top 5% of all pixels in change of pipeline TKR prediction output metric.
Odds ratios, 95% confidence intervals calculated using Cornfield’s method, and p values calculated using Fisher’s exact test are
displayed. Tissues significant at α = 0.05 are designated with a *. n = 124 for all tests.
classification rather than overall AUC, explaining why our integrated model has a lower overall AUC than our image-only
model. However, due to this decision, we obtained strong performance at early and moderate OA stages, with sensitivity and
specificity of 92.2±1.68% and 82.4±0.173% at no OA, respectively, and 78.9±0.974% and 74.7±0.228% at moderate OA
(intervals calculated using s.e.m., p < 0.05). In particular, the AUC of 0.943±0.029 (interval calculated with s.d., p < 0.05)
obtained by the MRI pipeline for patients without OA, the most difficult OA classification from which to predict TKR, by far
surpasses that of past TKR predictive models that include patients across all stages of OA. This performance marks progress
towards a model that identifies patients at risk for TKR such that nonsurgical treatment strategies can be implemented to delay
TKR.
The biomarker analysis conducted also has implications, as it identified several tissues located within or near the tibiofemoral
joint as reducing risk of TKR when identified as hotspots by the full MRI pipeline—namely, these were medially and laterally
located cartilage and bone, all examined meniscal regions, and the ACL. These tissues or damage within them all have been
associated with progression or onset of OA, and that our model shows TKR onset to be less reliant on these imaging features
in cases compared to controls demonstrates TKR onset to be a more complicated problem than OA progression, despite the
relationship between the two. On the other hand, the model identifies three tissues as increasing risk of TKR when identified
as hotspots in the pipeline: the medial patellar retinaculum, gastrocnemius tendon, and plantaris muscle. The medial patellar
retinaculum is crucial for lateral stabilization of the knee joint, and as such, damage to it results in a patella that more easily
dislocates50. Past work has shown patellar dislocation increases risk for OA, and TKR can be an effective procedure to treat
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inveterate patellar dislocation, showing a previous link between this tissue’s functionality and eventual OA and TKR51, 52. The
gastrocnemius tendon and plantaris muscle, on the other hand, are both posteriorly located tissues within the knee that play
a key role in knee flexion53. While literature regarding the plantaris muscle is rather sparse, injuries to the muscle can be
implicated in knee and calf pain felt by a patient54. Given their related functionality and location, the gastrocnemius tendon and
plantaris muscle can jointly be implicated in conditions such as “tennis leg,” which refers to mid-calf pain felt during extension
of the leg, usually due to damage to one of these tissues or their associated muscles or tendons55. The significance of the
plantaris muscle and gastrocnemius tendon to OA progression and TKR, however, have not been well characterized, and these
results justify future studies to these ends.
This study had some limitations. The first is specific to the OAI dataset, which tends towards older, female patients, all
from the United States: across 4,796 patients, the mean age is 61 years and 58% of patients are female. This is not emblematic
of the general population, so the robustness of the pipeline could be strengthened by testing on a dataset such as the Multicenter
Osteoarthritis Study (MOST). A further limitation of the dataset is that, despite the fairly large size, there are a very limited
number of patients with the classification of most interest: those without radiographic OA that still undergo TKR within 5
years. Only 66 such cases existed in the entire OAI dataset, and 12 were in the test set. As such, the OAI dataset and the
number of comparison experiments we ran within and across OA classifications limits the statistical power of our conclusions.
Furthermore, in this study, pixels in MRI images were compressed to 14 possible values to optimize performance—a version
of the pipeline was also constructed and evaluated without the compression, but its TKR prediction performance was not as
strong. Ideally, a model that uses all available information would be used in occlusion map analysis to draw more precise
conclusions regarding anatomic regions that associate with TKR, but this compromise was necessary to improve performance.
A final limitation was computational intensity in occlusion map generation: the voxel size and stride used were 12×32×32
and 12, respectively. These ideally would be smaller so maps could yield more precise insights but doing so was infeasible in a
reasonable amount of time.
To conclude, this work presents a predictive model that delivers performance not previously seen in predicting TKR,
especially for patients without OA. By delivering such performance, this pipeline can identify patients at risk of TKR with high
sensitivity and specificity, and for patients with no or moderate OA, this can allow a non-invasive treatment to be implemented
that prolongs good health of the knee and delays TKR. The biomarker analysis identifies the medial patellar retinaculum,
gastrocnemius tendon, and plantaris muscle as increasing risk of TKR when identified as a hotspot by the model, while its
assessment that several tissues within and near the tibiofemoral joint appear to reduce risk of TKR helps demonstrate the added
complexity of predicting TKR onset as opposed to OA progression. Beyond this, additional directions include investigating a
more effective means of integrating non-image information with image predictions to improve TKR prediction performance,
assessing the efficacy of alternate network architectures, and reducing computational time to make predictions.
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Supplementary Figures
Figure 5. Sample slices of DESS MRI and their corresponding compressed versions when rounding pixel values after
normalization.
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Variable grouping Variable Source
Demographics
Age (Lewis, 2013)22
Obesity/BMI (Lewis, 2013)22
Gender (Heidari, 2011)33
Ethnicity (Yu, 2019)23
Income (Hawker, 2006)21
Education level (Pisters, 2012)35
Previous knee trauma and pain
Knee pain (Lewis, 2013)22
Previous knee trauma (Heidari, 2011)33
Repetitive knee trauma (Heidari, 2011)33
Previous meniscal injuries (Heidari, 2011)33
Previous knee injury (Cooper, 2000)34
Knee physical activity and functionality
Mechanical forces exerted on knee (Heidari, 2011)33
Frequent kneeling (Heidari, 2011)33
Frequent squatting (Heidari, 2011)33
Physical activity level (Pisters, 2012)35
Muscular weakness (Heidari, 2011)33
Joint range of motion (Pisters, 2012)35
Lower knee extension muscle strength (Pisters, 2012)35
Previous actions to treat knee pain
Previous joint injections (Yu, 2019)23
Previous knee arthroscopy (Yu, 2019)23
Previous analgesics or opioid usage (Lewis, 2013)22
Previous NSAID usage (Yu, 2019)23
Number of previous knee referrals (Yu, 2019)23
Number of previous consultations (Yu, 2019)23
Willingness to consider TJA as treatment (Hawker, 2006)21
Seen physician for arthritis in previous year (Hawker, 2006)21
Preexisting health conditions
Heberden’s nodes (Cooper, 2000)34
Recorded diagnosis of joint-specific OA (Yu, 2019)23
Low back pain (Yu, 2019)23
Hypertension (Yu, 2019)23
Smoking status (Yu, 2019)23
Drinking status (Yu, 2019)23
Asthma (Yu, 2019)23
COPD (Yu, 2019)23
Diabetes mellitus (Yu, 2019)23
Comorbidities (Pisters, 2012)35
Miscellaneous
Knee joint laxity (Heidari, 2011)33
Genetic susceptibility to knee OA (Heidari, 2011)33
Mental health measures (Sharma, 2003)36
SF36 score (Hawker, 2006)21
Table 6. Non-imaging variables identified from literature as correlated with OA progression or eventual TKR. These
non-imaging variables were taken to the OAI database, and, if present, added as potential non-imaging variables to supplement
image-based predictions.
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Tissue type Tissue No OA(n = 11)
Moderate OA
(n = 65)
Severe OA
(n = 48)
Total
(n = 124)
Cartilage
TFJ medial 100 95.4 87.5 92.7
TFJ lateral 100 87.7 85.4 87.9
PFJ 27.3 43.1 41.7 41.1
Meniscus
Medial anterior 100 84.6 75.0 82.3
Medial posterior 90.9 87.7 70.8 81.5
Lateral anterior 100 87.7 81.3 86.3
Lateral posterior 100 90.8 81.3 87.9
Bone
TFJ medial 100 95.4 89.6 93.5
TFJ lateral 90.9 87.7 83.3 86.3
PFJ 27.3 35.4 45.8 38.7
Ligament
ACL 100 81.5 64.6 76.6
PCL 72.7 73.8 77.1 75.0
Popliteal 54.5 56.9 58.3 57.3
Tendon
Medial patellar retinaculum 90.9 78.5 91.7 84.7
Lateral patellar retinaculum 54.5 21.5 33.3 29.0
Popliteal 36.4 49.2 43.8 46.0
Patellar 27.3 27.7 25.0 26.6
Gastrocnemius 36.4 9.2 14.6 13.7
Semimembranosus 27.3 13.8 6.3 12.1
Quadriceps 0.0 4.6 14.6 8.1
Gracilis 0.0 4.6 6.3 4.8
Fat Pad Hoffa 100 90.8 97.9 94.4
Muscle
Popliteus 18.2 35.4 10.4 24.2
Vastus medialis 18.2 7.7 18.8 12.9
Gastrocnemius 36.4 26.2 27.1 27.4
Plantaris 27.3 32.3 31.3 31.5
Biceps femoris 0.0 4.6 6.3 4.8
Tibialis anterior 0.0 4.6 0.0 2.4
Semimembranosus 0.0 3.1 2.1 2.4
Synovium General 81.8 87.7 93.8 89.5
Table 7. Percentages of selected tissues identified as hotspots among 124 true positives detected by integrated MRI pipeline,
stratified by OA severity.
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Tissue type Tissue No OA(n = 11)
Moderate OA
(n = 65)
Severe OA
(n = 48)
Total
(n = 124)
Cartilage
TFJ medial 100 100 100 100
TFJ lateral 100 100 100 100
PFJ 18.2 27.7 62.5 40.3
Meniscus
Medial anterior 100 92.3 93.8 93.5
Medial posterior 100 96.9 83.3 91.9
Lateral anterior 90.9 96.9 97.9 96.8
Lateral posterior 100 100 91.7 96.8
Bone
TFJ medial 100 100 97.9 99.2
TFJ lateral 100 100 100 100
PFJ 9.1 26.2 56.3 36.3
Ligament
ACL 100 90.8 79.2 87.1
PCL 45.5 63.1 72.9 65.3
Popliteal 54.5 46.2 41.7 45.2
Tendon
Medial patellar retinaculum 54.5 66.2 87.5 73.4
Lateral patellar retinaculum 18.2 23.1 35.4 27.4
Popliteal 45.5 33.8 37.5 36.3
Patellar 9.1 16.9 18.8 16.9
Gastrocnemius 0.0 9.2 0.0 4.8
Semimembranosus 36.4 26.2 12.5 21.8
Quadriceps 0.0 0.0 6.3 2.4
Gracilis 0.0 1.5 0.0 0.8
Fat Pad Hoffa 81.8 81.5 95.8 87.1
Muscle
Popliteus 18.2 15.4 10.4 13.7
Vastus medialis 0.0 7.7 16.7 10.5
Gastrocnemius 45.5 29.2 6.3 21.8
Plantaris 18.2 15.4 10.4 13.7
Biceps femoris 0.0 1.5 0.0 0.8
Tibialis anterior 9.1 0.0 0.0 0.8
Semimembranosus 27.3 7.7 2.1 7.3
Synovium General 90.9 87.7 87.5 87.9
Table 8. Percentages of selected tissues identified as hotspots among 124 true negative controls detected by integrated MRI
pipeline, stratified by OA severity.
18/18
